US FDA approves Alnylam’s drug for rare heart condition

17425083111119865v1uqoeusm683615

(Reuters) -U.S. Food and Drug Administration approved Alnylam’s drug to treat a rare and deadly heart disease on Thursday, allowing the entry of a new type of medicine in a market dominated by Pfizer’s blockbuster Vyndaqel. The injectable